NEW YORK, Sept. 01, 2020 (GLOBE NEWSWIRE) --

Otelco Inc. (NASDAQ: OTEL)

Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of OTEL to Oak Hill Capital for $11.75 per share.

If you are an OTEL investor, and would like additional information about our investigation, please complete the Information Request Form.

Pfenex Inc. (NYSE: PFNX)

Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of PFNX to Ligand Pharmaceuticals Incorporated.

If you are a PFNX investor, and would like additional information about our investigation, please complete the Information Request Form.

Spring Bank Pharmaceuticals, Inc. (NASDAQ: SBPH)

Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of SBPH to F-star Therapeutics, Limited.

If you are a SBPH  investor, and would like additional information about our investigation, please complete the Information Request Form.

Varian Medical Systems, Inc. (NYSE: VAR)

Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of VAR to Siemens Healthineers AG for $177.50 per share.

If you are a VAR investor, and would like additional information about our investigation, please complete the Information Request Form.

ATTORNEY ADVERTISING.© 2020 Lifshitz Law Firm, P.C.  The law firm responsible for this advertisement is Lifshitz Law Firm, P.C., 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: (516)493-9780.  Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:
Joshua M. Lifshitz, Esq.
Lifshitz Law Firm, P.C.
Phone:  516-493-9780
Facsimile: 516-280-7376
Email: info@jlclasslaw.com

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.